DE60137417D1 - Zellproliferation-inhibitoren - Google Patents

Zellproliferation-inhibitoren

Info

Publication number
DE60137417D1
DE60137417D1 DE60137417T DE60137417T DE60137417D1 DE 60137417 D1 DE60137417 D1 DE 60137417D1 DE 60137417 T DE60137417 T DE 60137417T DE 60137417 T DE60137417 T DE 60137417T DE 60137417 D1 DE60137417 D1 DE 60137417D1
Authority
DE
Germany
Prior art keywords
cell proliferation
proliferation inhibitors
pthrp
inhibitors
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137417T
Other languages
English (en)
Inventor
Akira Yoshida
Syunsuke Yanoma
Fumikazu Hirose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26591317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60137417(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60137417D1 publication Critical patent/DE60137417D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
DE60137417T 2000-04-28 2001-04-26 Zellproliferation-inhibitoren Expired - Lifetime DE60137417D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000131793 2000-04-28
JP2000173834 2000-06-09
PCT/JP2001/003665 WO2001082968A1 (fr) 2000-04-28 2001-04-26 Inhibiteurs de proliferation cellulaire

Publications (1)

Publication Number Publication Date
DE60137417D1 true DE60137417D1 (de) 2009-03-05

Family

ID=26591317

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137417T Expired - Lifetime DE60137417D1 (de) 2000-04-28 2001-04-26 Zellproliferation-inhibitoren

Country Status (7)

Country Link
US (1) US8029793B2 (de)
EP (2) EP1283057B2 (de)
JP (1) JP4846169B2 (de)
AT (1) ATE420661T1 (de)
AU (1) AU2001252618A1 (de)
DE (1) DE60137417D1 (de)
WO (1) WO2001082968A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841788B1 (fr) * 2002-07-05 2006-01-27 Univ Pasteur Utilisation d'antagonistes de la pthrp pour traiter le carcinome a cellules renales
JPWO2004045643A1 (ja) * 2002-11-18 2006-03-16 中外製薬株式会社 軟骨腫・軟骨肉腫治療剤
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
BRPI0507088A (pt) 2004-01-26 2007-06-19 Renessen Llc alimento de soja com alto teor de proteìna
GB2471693A (en) * 2009-07-08 2011-01-12 Complix Nv Parathyroid hormone related protein antagonists
US11717593B2 (en) * 2013-03-13 2023-08-08 Avery Dennison Corporation Improving adhesive properties

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPH0759763B2 (ja) 1986-03-24 1995-06-28 株式会社バイオマテリアル・ユニバース 高強度、高弾性率ポリビニルアルコ−ル繊維およびその製造法
EP0293158A3 (de) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
EP0293130A3 (de) 1987-05-26 1990-06-13 Merck & Co. Inc. Dimere von Parathyroid-Hormon-Antagonisten
US5001223A (en) 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US4771124A (en) 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Ind Co Ltd Semiconductor laser protective circuit
DE68908175T2 (de) 1988-05-27 1994-03-03 Centocor Inc Gefriergetrocknete formulierung für antikörperprodukte.
EP0417191B1 (de) 1988-05-27 1993-03-10 Centocor, Inc. Formulierung für antikörper enthaltende reagenzien
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5217896A (en) 1988-12-30 1993-06-08 Oncogene Science, Inc. Monoclonal antibodies recognizing parathyroid hormone-like protein
JPH02207099A (ja) 1989-02-07 1990-08-16 Tonen Corp ＰＴＨｒＰ関連ペプチド、その製造法及び用途
CA2035179C (en) 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
GB9009548D0 (en) 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
JPH04228089A (ja) 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
WO1992000753A1 (en) 1990-07-13 1992-01-23 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
DE69233472T2 (de) 1991-04-05 2006-02-09 The General Hospital Corp., Charlestown Parathormonrezeptor und dafür codierende DNA
EP0628639B1 (de) 1991-04-25 1999-06-23 Chugai Seiyaku Kabushiki Kaisha Rekombinierte humane antikörper gegen den humanen interleukin 6-rezeptor
EP0746609A4 (de) 1991-12-17 1997-12-17 Genpharm Int Heterologe antikörper produzierende transgene nicht-humane tiere
AU3095892A (en) 1991-12-20 1993-07-28 Protein Design Labs, Inc. Human type antibody reactive with GPIIb/IIIa
WO1994002602A1 (en) 1992-07-24 1994-02-03 Cell Genesys, Inc. Generation of xenogeneic antibodies
US5648267A (en) 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
US5849695A (en) 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JP3504697B2 (ja) 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
JPH07316195A (ja) 1994-05-25 1995-12-05 Nippon Kayaku Co Ltd 新規なＰＴＨｒＰ関連ペプチド及びその用途
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
CO4410206A1 (es) 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US5993817A (en) 1995-01-23 1999-11-30 Xenotech Method to ameliorate osteolysis and metastasis
EP0813423B1 (de) 1995-01-23 2002-07-03 Xenotech Incorporated Zusammensetzung zur verhinderung von osteolyse und metastasen
US5626845A (en) 1995-01-23 1997-05-06 Xenotech Incorporated Method to ameliorate osteolysis and metastasis
EP0811383B1 (de) 1995-02-20 2007-05-30 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
DE69610826T2 (de) 1995-03-01 2001-05-03 Stryker Corp Morphogeninduzierte regenerierung der dentin
AU5632296A (en) 1995-04-27 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5660826A (en) 1995-06-06 1997-08-26 The Regents Of The University Of California Therapeutic sepsis treatment using antagonists to PTHrP
WO1997027870A1 (fr) 1996-02-01 1997-08-07 Chugai Seiyaku Kabushiki Kaisha Medicaments prevenant ou guerissant la thrombopenie
WO1998011218A1 (en) 1996-09-10 1998-03-19 Theodor-Kocher Institute Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
BR9713294A (pt) 1996-09-26 2000-10-17 Chugai Pharmaceutical Co Ltd "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
JP4372240B2 (ja) 1997-05-15 2009-11-25 中外製薬株式会社 悪液質治療剤
BR9809629A (pt) * 1997-05-15 2000-07-04 Chugai Pharmaceutical Co Ltd Agente terapêutico para caquexia
JP4414494B2 (ja) 1998-02-03 2010-02-10 旭化成ファーマ株式会社 白血球減少症の予防剤および治療剤
CA2327509A1 (en) 1998-05-05 1999-11-11 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Pth2 receptor selective compounds
JP2000080100A (ja) * 1998-06-17 2000-03-21 Japan Tobacco Inc 副甲状腺ホルモン関連タンパクに対するヒトモノクローナル抗体
CZ20004753A3 (cs) 1998-06-26 2002-06-12 Chugai Seiyaku Kabushiki Kaisha Terapeutické činidlo na hyperkalcinemickou krizi
JP2000131793A (ja) 1998-10-27 2000-05-12 Konica Corp 熱現像感光材料の製造方法、これにより製造した熱現像感光材料を用いた画像記録方法及び画像形成方法
JP2000173834A (ja) 1998-12-10 2000-06-23 Mitsubishi Electric Corp シート巻静止誘導電器

Also Published As

Publication number Publication date
EP1283057A1 (de) 2003-02-12
ATE420661T1 (de) 2009-01-15
EP1283057B1 (de) 2009-01-14
EP1987842A1 (de) 2008-11-05
AU2001252618A1 (en) 2001-11-12
US20040001824A1 (en) 2004-01-01
US8029793B2 (en) 2011-10-04
JP4846169B2 (ja) 2011-12-28
EP1283057B2 (de) 2012-05-30
WO2001082968A1 (fr) 2001-11-08
EP1283057A4 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
FI971489A (fi) Uusia bentsoksatsoleja
TR200002618T2 (tr) Sübstitüe edilmiş heterosiklik üreler kullanılarak raf kinazın inhibe edilmesi
NO20052989D0 (no) Terapeutiske forbindelser.
NL300242I2 (nl) Omega-carboxyaryl gesubstitueerde difenylureums als raf kinaseremmers.
EE05430B1 (et) Imidasolo-5-l-2-anilino-primidiinid raku proliferatsiooni inhibitsiooni agensitena
TR199902368T2 (xx) S�lfonamid t�revleri.
IS5711A (is) Heteróhringatálmar við P38
ATE380806T1 (de) 2-amino-3-(alkyl)-pyrimidonderivate als gsk3.beta.-hemmer
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
DE69905582D1 (de) Heterocyclische verbindungen als rotamase-enzymen inhibitoren
DK1129501T3 (da) Bipolar plade til brandselscelle
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
DK0981525T3 (da) (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling
DE60137417D1 (de) Zellproliferation-inhibitoren
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
ITRM990426A0 (it) Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi.
TR199902929T2 (xx) Yeni proses.
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
ID30351A (id) Derivatip-derivatip 2,3-0-isopropylidene monosakarida sebagai penghambat perekatan sel
EE200300156A (et) Kasvajarakkude kasvufaktoritest sõltuvuse pärssimine
DE60011300D1 (de) Inhibitoren der tryptase
ATE262339T1 (de) Purinriboside als antiarrhythmika
NO20022776D0 (no) Substituerte bisindolylmaleimider for inhibering av celleproliferasjon
WO2002024227A1 (fr) Inhibiteurs de proliferation de cellules tumorales

Legal Events

Date Code Title Description
8363 Opposition against the patent